United Therapeutics Corporation – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: UTHR
Share price (5/5/26): $572.20
Market cap (5/5/26): $24.3 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 86 pages Exclusive License Agreement by and Between Arena Pharmaceuticals, Inc. (“Arena”) United Therapeutics Corporation (“Ut”) Dated as of November 15, 2018

from 8-K 122 pages Agreement and Plan of Merger Among United Therapeutics Corporation, Daniel 24043 Acquisition Corp. Ltd. and Steadymed Ltd. Dated as of April 29, 2018

from 8-K 30 pages Asset Purchase Agreement by and Between Abbvie Ireland Unlimited Company and United Therapeutics Corporation August 18, 2015

from SC 13D 3 pages Confidentiality Agreement

from SC 13D 28 pages Stock Purchase Agreement Between Eli Lilly and Company (The “Purchaser”) and United Therapeutics Corporation (The “Company”), Dated as of November 14, 2008

from 8-K/A ~5 pages Escrow Agreement

from 8-K/A ~5 pages Escrow Agreement

from 8-K/A ~10 pages Registration Rights Agreement

from 8-K/A ~10 pages Registration Rights Agreement

from 8-K/A ~50 pages Asset Purchase Agreement

from 8-K/A ~50 pages Asset Purchase Agreement